CEO Linda Tharby to retire June 2026; Adam Kalbermatten named successor

KORU Medical Systems, Inc.

Tharby retires as CEO effective June 30, 2026; will serve as advisory employee through Dec 31, 2026.
Kalbermatten appointed President March 15, 2026, and becomes CEO July 1, 2026.
Kalbermatten's base salary: $450K through June, then $525K; 2026 bonus target 80%; LTI target $1.25M.
One-time PSU award of $1.25M to Kalbermatten effective July 1, 2026 with performance goals (75% revenue growth, 25% market cap).
Tharby's equity: some PSUs/RSUs continue vesting through Dec 31, 2026; all remaining unvested awards forfeited thereafter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.